Ikarian Capital’s Chimerix, Inc. CMRX Stock Holding History

Ikarian Capital’s Portfolio CMRX Stock Details CMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-150,000	Closed	-$1.45M	–	302
2021 Q1	$1.45M	Buy	+150,000	New	+$1.38M	0.05%	221

Other funds holding CMRX

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ikarian Capital's CMRX Position: Q3 2022 in Review

Ikarian Capital sold out of Chimerix, Inc. (CMRX) in Q3 2022, closing a stake of 441,203 shares — an estimated $917K sold.

Ikarian Capital first reported a position in CMRX in Q4 2019 and held it in 10 quarters. The position peaked at $15.4M in Q1 2021. 118 funds tracked by Wall St. Rank hold CMRX as of Q3 2022.

Ikarian Capital reported no remaining Chimerix, Inc. position as of Q3 2022 after selling out during the quarter.
Ikarian Capital sold 441,203 Chimerix, Inc. shares in Q3 2022, an estimated $917K.
Ikarian Capital first reported a position in Chimerix, Inc. in Q4 2019 and held it in 10 quarters.
Ikarian Capital's Chimerix, Inc. position peaked at $15.4M in Q1 2021.
118 funds tracked by Wall St. Rank held Chimerix, Inc. as of Q3 2022.

Based on Ikarian Capital's 13F filing for Q3 2022, filed 14 Nov 2022.